Future Medicine Co., Ltd. (XKON:341170)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,005.00
+5.00 (0.25%)
At close: Apr 28, 2026
25.31%
Market Cap 21.12B
Revenue (ttm) 1.00B
Net Income (ttm) -13.37B
Shares Out 10.53M
EPS (ttm) -1,637.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,582
Average Volume 8,798
Open 2,100.00
Previous Close 2,000.00
Day's Range 1,880.00 - 2,100.00
52-Week Range 714.00 - 3,300.00
Beta -0.33
RSI 45.42
Earnings Date n/a

About Future Medicine

Future Medicine Co., Ltd. operates as a drug development company worldwide. It develops therapeutic drugs for non-alcoholic liver disease treatment and the anticancer field. The company was founded in 2015 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 26
Stock Exchange Korea New Exchange
Ticker Symbol 341170
Full Company Profile

Financial Performance

News

There is no news available yet.